Literature DB >> 15643603

Distinct novel mutations affecting the same base in the NIPA1 gene cause autosomal dominant hereditary spastic paraplegia in two Chinese families.

Suqin Chen1, Chun Song, Hui Guo, Pingyi Xu, Weijun Huang, Yan Zhou, Jiandong Sun, Cai-Xia Li, Yong Du, Xunhua Li, Zhuolin Liu, Deqin Geng, Patrick H Maxwell, Cheng Zhang, Yiming Wang.   

Abstract

Hereditary spastic paraplegia (HSP) is a neurodegenerative disease characterized by lower-limb spasticity, hyperreflexia, progressive spastic gait abnormalities, and an extensor-plantar response. It is genetically very heterogeneous, with 28 Human Genome Organisation (HUGO)-approved IDs in the database (last search: August 8, 2004). Following the identification of the SPG6 gene, NIPA1, we have identified two novel mutations, c.316G>C and c.316G>A, in two independent Chinese families linked to the SPG6 locus. These two mutations would cause a p.G106R substitution, and cosegregated with the disease. Structural predictions suggest that p.G106 is located in the third transmembrane domain of the protein, and that the mutant p.G106R disrupts this structure, causing the intramembrane loop to descend into the cytoplasm. Our results identify two novel mutations responsible for HSP and suggest that c.316 of theNIPA1 gene may be a mutational hotspot. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643603     DOI: 10.1002/humu.20126

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

1.  TDP-43 pathology in a case of hereditary spastic paraplegia with a NIPA1/SPG6 mutation.

Authors:  Maria Martinez-Lage; Laura Molina-Porcel; Dana Falcone; Leo McCluskey; Virginia M-Y Lee; Vivianna M Van Deerlin; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2012-08       Impact factor: 17.088

2.  Drosophila spichthyin inhibits BMP signaling and regulates synaptic growth and axonal microtubules.

Authors:  Xinnan Wang; W Robert Shaw; Hilda T H Tsang; Evan Reid; Cahir J O'Kane
Journal:  Nat Neurosci       Date:  2007-01-14       Impact factor: 24.884

3.  NIPA1 (SPG6) mutations are a rare cause of autosomal dominant spastic paraplegia in Europe.

Authors:  Stephan Klebe; Arnaud Lacour; Alexandra Durr; Tanya Stojkovic; Christel Depienne; Sylvie Forlani; Sandrine Poea-Guyon; Isabelle Vuillaume; Bernard Sablonniere; Patrick Vermersch; Alexis Brice; Giovanni Stevanin
Journal:  Neurogenetics       Date:  2007-01-05       Impact factor: 2.660

4.  Microarray based comparative genomic hybridization testing in deletion bearing patients with Angelman syndrome: genotype-phenotype correlations.

Authors:  T Sahoo; S U Peters; N S Madduri; D G Glaze; J R German; L M Bird; R Barbieri-Welge; T J Bichell; A L Beaudet; C A Bacino
Journal:  J Med Genet       Date:  2005-09-23       Impact factor: 6.318

5.  The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1.

Authors:  Emmanuel J Botzolakis; Jiali Zhao; Katharine N Gurba; Robert L Macdonald; Peter Hedera
Journal:  Mol Cell Neurosci       Date:  2010-09-21       Impact factor: 4.314

Review 6.  Clinical and genetic aspects of the 15q11.2 BP1-BP2 microdeletion disorder.

Authors:  M G Butler
Journal:  J Intellect Disabil Res       Date:  2017-04-07

7.  Microduplications at the 15q11.2 BP1-BP2 locus are enriched in patients with anorexia nervosa.

Authors:  Xiao Chang; Huiqi Qu; Yichuan Liu; Joseph Glessner; Cuiping Hou; Fengxiang Wang; Jin Li; Patrick Sleiman; Hakon Hakonarson
Journal:  J Psychiatr Res       Date:  2019-01-29       Impact factor: 4.791

8.  Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism.

Authors:  Jiali Zhao; Dawn S Matthies; Emmanuel J Botzolakis; Robert L Macdonald; Randy D Blakely; Peter Hedera
Journal:  J Neurosci       Date:  2008-12-17       Impact factor: 6.167

Review 9.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms.

Authors:  John K Fink
Journal:  Acta Neuropathol       Date:  2013-07-30       Impact factor: 17.088

Review 10.  Hereditary spastic paraplegia.

Authors:  John K Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2006-01       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.